Peter J. van Santbrink

1.7k citations

35 papers · 1.2k indexed · h-index 20

Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases 16
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 5
- Immune cells in cancer 4
Immunology and Allergy top 10%
Molecular Biology
- Inflammasome and immune disorders 3
Cancer Research
Physiology top 10%
Oncology
- Drug Transport and Resistance Mechanisms 3
- Chemokine receptors and signaling 3
Surgery
- Cholesterol and Lipid Metabolism 3

Co-authors: Ilze Bot Johan Kuiper Amanda C. Foks Janine van Duijn Erik A.L. Biessen Thomas van der Heijden Eva Kritikou Bram Slütter
Cited by: Immunology Immunology and Allergy Molecular Biology
Journals: Circulation (1 paper)Blood (1 paper)The Journal of Immunology (1 paper)
Partner nations: Netherlands United States China

In The Last Decade

Peter J. van Santbrink

33 papers receiving 1.2k citations

Peers

Countries citing papers authored by Peter J. van Santbrink

Since Specialization

Citations

This map shows the geographic impact of Peter J. van Santbrink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. van Santbrink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. van Santbrink more than expected).

Fields of papers citing papers by Peter J. van Santbrink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. van Santbrink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. van Santbrink. The network helps show where Peter J. van Santbrink may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter J. van Santbrink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter J. van Santbrink Line = papers co-authored together Peter J. van Santbrink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	NLRP3 Inflammasome Inhibition by the Novel Bispecific Antibody InflamAb Attenuates Atherosclerosis in Apolipoprotein E–Deficient Mice JACC Basic to Translational Science ·Lucie Delfos,Marie A.C. Depuydt,Melody Chemaly,Sophie Coyle,Frank H. Schaftenaar,Peter J. van Santbrink,Pier Pieterszoon Lindenbergh,Mireia N. A. Bernabé Kleijn,C. Costello,Christopher Power,Rebecca C. Coll,Aaron Peace,Meredith Gregory‐Ksander,Amanda C. Foks,Johan Kuiper,Victoria McGilligan,Ilze Bot	2025	1
2	Immunosenescence accelerates atherosclerosis development in AAV-PCSK9 mouse model GeroScience ·Jill de Mol,Virginia Smit,Mireia N. A. Bernabé Kleijn,Peter J. van Santbrink,Ilze Bot,Amanda C. Foks	2025	0
3	Leukemia inhibitory factor receptor inhibition by EC359 reduces atherosclerotic stenosis grade in Ldlr mice European Journal of Pharmacology ·Esmeralda Hemme,Marie A.C. Depuydt,Peter J. van Santbrink,Anouk Wezel,H.J. Smeets,Amanda C. Foks,Johan Kuiper,Ilze Bot	2024	1
4	Immunoproteasomal Inhibition With ONX-0914 Attenuates Atherosclerosis and Reduces White Adipose Tissue Mass and Metabolic Syndrome in Mice Arteriosclerosis Thrombosis and Vascular Biology ·Frank H. Schaftenaar,Andrea D. van Dam,Gerjan de Bruin,Marie A.C. Depuydt,Jill de Mol,Jacob Amersfoort,Hidde Douna,Menno Meijer,Mara J. Kröner,Peter J. van Santbrink,Mireia N. A. Bernabé Kleijn,Gijs H.M. van Puijvelde,Bogdan I. Florea,Bram Slütter,Amanda C. Foks,Ilze Bot,Patrick C.N. Rensen,Johan Kuiper	2024	4
5	Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe−/− mice Atherosclerosis ·Ilze Bot,Lucie Delfos,Esmeralda Hemme,Mireia N. A. Bernabé Kleijn,Peter J. van Santbrink,Amanda C. Foks,Petri T. Kovanen,Annukka Jouppila,Riitta Lassila	2024	2
6	Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells Cardiovascular Research ·Jacob Amersfoort,Frank H. Schaftenaar,Hidde Douna,Peter J. van Santbrink,Gijs H.M. van Puijvelde,Bram Slütter,Amanda C. Foks,Amy C. Harms,Estefanía Moreno-Gordaliza,Yanyan Wang,Thomas Hankemeier,Ilze Bot,Hongbo Chi,Johan Kuiper	2020	24
7	Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model Atherosclerosis ·Joya E. Nahon,Menno Hoekstra,Stefan R. Havik,Peter J. van Santbrink,Geesje M. Dallinga‐Thie,J.A. Kuivenhoven,Janine J. Geerling,Miranda Van Eck	2018	13
8	CD11b⁺Gr-1⁺myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice Cardiovascular Research ·Amanda C. Foks,Gijs H.M. van Puijvelde,Jolien Wolbert,Mara J. Kröner,Vanessa Frodermann,Thomas van der Heijden,Peter J. van Santbrink,Louis Boon,Ilze Bot,Johan Kuiper	2016	32
9	Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice Scientific Reports ·Eva Kritikou,Gijs H.M. van Puijvelde,Thomas van der Heijden,Peter J. van Santbrink,Maarten Swart,Frank H. Schaftenaar,Mara J. Kröner,Johan Kuiper,Ilze Bot	2016	29
10	Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development Scientific Reports ·Vanessa Frodermann,Janine van Duijn,Melissa van Pel,Peter J. van Santbrink,Ilze Bot,Johan Kuiper,Saskia C.A. de Jager	2015	52
11	Oxidized Low-Density Lipoprotein–Induced Apoptotic Dendritic Cells as a Novel Therapy for Atherosclerosis The Journal of Immunology ·Vanessa Frodermann,Gijs H.M. van Puijvelde,Laura Wierts,H. Maxime Lagraauw,Amanda C. Foks,Peter J. van Santbrink,Ilze Bot,Johan Kuiper,Saskia C.A. de Jager	2015	18
12	Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development PLoS ONE ·Amanda C. Foks,Ingrid A. Ran,Vanessa Frodermann,Ilze Bot,Peter J. van Santbrink,Johan Kuiper,Gijs H.M. van Puijvelde	2013	11
13	Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice PLoS ONE ·Martine Bot,Paul P. Van Veldhoven,Saskia C.A. de Jager,Jason L. Johnson,Niels Nijstad,Peter J. van Santbrink,Marijke M. Westra,Gerd Van der Hoeven,Marion J. Gijbels,Carsten Müller‐Tidow,Georg Varga,Uwe J.F. Tietge,Johan Kuiper,Theo J.C. van Berkel,Jerzy–Roch Nofer,Ilze Bot,Erik A.L. Biessen	2013	24
14	T-Cell Immunoglobulin and Mucin Domain 3 Acts as a Negative Regulator of Atherosclerosis Arteriosclerosis Thrombosis and Vascular Biology ·Amanda C. Foks,Ingrid A. Ran,Loes Wasserman,Vanessa Frodermann,Mariëtte N. D. ter Borg,Saskia C.A. de Jager,Peter J. van Santbrink,Hideo Yagita∥,Hisaya Akiba,Ilze Bot,Johan Kuiper,Gijs H.M. van Puijvelde	2013	47
15	Adenosine A _2B Receptor Agonism Inhibits Neointimal Lesion Development After Arterial Injury in Apolipoprotein E–Deficient Mice Arteriosclerosis Thrombosis and Vascular Biology ·Ilze Bot,Henk de Vries,Suzanne J.A. Korporaal,Amanda C. Foks,Martine Bot,Jacobus van Veldhoven,Mariëtte N. D. ter Borg,Peter J. van Santbrink,Theo J.C. van Berkel,Johan Kuiper,Adriaan P. IJzerman	2012	22
16	Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice Atherosclerosis ·Laura Calpe‐Berdiel,Ying Zhao,Marjo de Graauw,Dan Ye,Peter J. van Santbrink,A. Mieke Mommaas,Amanda C. Foks,Martine Bot,Illiana Meurs,Johan Kuiper,Jody T. Mack,Miranda Van Eck,Kenneth D. Tew,Theo J.C. van Berkel	2012	13
17	Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease Cardiovascular Research ·Margreet R. de Vries,Anouk Wezel,Abbey Schepers,Peter J. van Santbrink,Trent M. Woodruff,Hans W.M. Niessen,Jaap F. Hamming,Johan Kuiper,Ilze Bot,Paul H.A. Quax	2012	48
18	Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE−/− mice Cardiovascular Research ·Ilze Bot,Martine Bot,Sandra H. van Heiningen,Peter J. van Santbrink,Inge M. Lankhuizen,Peter Hartman,Sabine Gruener,Hans Hilpert,Theo J.C. van Berkel,Jürgen Fingerle,Erik A.L. Biessen	2010	56
19	Impaired Effector Memory T-Cell Regulation Facilitates Graft Versus Host Disease in CCR7-Deficient Bone Marrow Transplant Chimeras Transplantation ·Saskia C.A. de Jager,Kirsten Canté-Barrett,Ilze Bot,Cathrine Husberg,Gijs H van Puijvelde,Peter J. van Santbrink,Arne Yndestad,Jessica M.E. van den Oever,Johan Kuiper,Theo J.C. van Berkel,Martin Lipp,Jaap Jan Zwaginga,W.E. Fibbe,Pål Aukrust,Erik A.L. Biessen	2009	4
20	Y-Box Binding Protein-1 Controls CC Chemokine Ligand-5 (CCL5) Expression in Smooth Muscle Cells and Contributes to Neointima Formation in Atherosclerosis-Prone Mice Circulation ·Regina M. Krohn,Ute Raffetseder,Ilze Bot,Alma Zernecke,Erdenechimeg Shagdarsuren,Elisa A. Liehn,Peter J. van Santbrink,Peter J. Nelson,Erik A.L. Biessen,Peter R. Mertens,Christian Weber	2007	87

About Peter J. van Santbrink

Peter J. van Santbrink is a scholar working on Immunology, Immunology and Allergy and Cancer Research, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (16 papers), Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (5 papers), Immune cells in cancer (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Chemokine receptors and signaling (3 papers), Inflammasome and immune disorders (3 papers) and Cholesterol and Lipid Metabolism (3 papers). The work is most often cited by research in Immunology (639 citations), Immunology and Allergy (65 citations) and Molecular Biology (630 citations). Peter J. van Santbrink has collaborated with scholars based in Netherlands, United States and China. Frequent co-authors include Ilze Bot, Johan Kuiper, Amanda C. Foks, Janine van Duijn, Erik A.L. Biessen, Thomas van der Heijden, Eva Kritikou, Bram Slütter, Theo J.C. van Berkel and Saskia C.A. de Jager. Their work appears in journals such as Circulation, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact